What your doctor is reading on Medscape.com: MARCH 27, 2020 — The European Medicines Agency (EMA) has issued a statement advising that patients continue treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), despite widely circulated reports that the agents could worsen coronavirus disease. “It is …
Read More »
The crux of the controversy is data suggesting that use of ACE inhibitors and ARBs may increase expression of ACE2, which leads to the hypothesis that these drugs may increase patient susceptibility to the virus. Several commentaries suggesting that ACE inhibitors and ARBs may increase susceptibility in this way have …
Read More »
What your doctor is reading on Medscape.com: MARCH 17, 2020 — Three American professional cardiology societies have issued a joint statement urging continuation of renin–angiotensin–aldosterone system (RAAS) antagonists in patients, despite theoretical concerns that their use might worsen outcomes in the event of infection with COVID-19. The new …
Read More »
What your doctor is reading on Medscape.com: MARCH 11, 2020, BOSTON — In the world of Ralph Baric, PhD, not much is a coincidence. So he perked up when he saw that SARS-CoV-2, the virus that causes COVID-19 illness, enters the lungs through ACE2 receptors, and that people with …
Read More »
What your doctor is reading on Medscape.com: MARCH 16, 2020 — The European Society of Cardiology (ESC) has issued a statement urging physicians and patients to continue treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), in light of a newly described theory that those agents …
Read More »
Create Your Website for Free Free Website Builder – eu.cx